亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北大華偉業醫藥化工有限公司  

該公司主要從事原料藥(API)及中間體生產和研發

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:艾天堯
  • 電話:027-59420981
  • 郵件:1933329534@qq.com
  • 傳真:430000
  • QQ:1933329534
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 禁發 鹽酸阿替卡因
禁發 鹽酸阿替卡因
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
過期 長期有效
更新 2014-02-09 09:04
 
詳細信息

禁發 鹽酸阿替卡因
禁發 鹽酸阿替卡因Articaine hydrochloride
化學名:4-甲基-3-[[1-氧代-2-(丙氨基)-丙基]氨基]-2-噻吩羧酸甲酯出現被限制詞語
分子式:C13H20O3N2S
分子量:320.84
CAS:23964-57-0
外觀:白色或類白色結晶性粉末
含量:≥98.5%
熔點:167~173℃
包裝:1kg聽,5kg聽,25kg聽
適應癥:口腔用局部嘛醉劑,特別適用于涉及切骨術及粘膜切開的外科手術過程
附加備注:禁發 鹽酸阿替卡因禁發 鹽酸阿替卡因Articaine hydrochloride化學名:4-甲基-3-[[1-氧代-2-(丙氨基)-丙基]氨基]-2-噻吩羧酸甲酯出現被限制詞語分子式:C13H20O3N2S分子量:320.84 CAS:23964-57-0外觀:白色或類白色結晶性粉末含量:≥98.5%熔點:167~173℃包裝:1kg聽,5kg聽,25kg桶適應癥:口腔用局部嘛醉劑,特別適用于涉及切骨術及粘膜切開的外科手術過程 
©2025 湖北大華偉業醫藥化工有限公司 版權所有   技術支持:化工網   訪問量:9627  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |